These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4856104)

  • 1. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia.
    Hökfelt T; Ljungdahl A; Fuxe K; Johansson O
    Science; 1974 Apr; 184(4133):177-9. PubMed ID: 4856104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex.
    Hökfelt T; Fuxe K; Johansson O; Ljungdahl A
    Eur J Pharmacol; 1974 Jan; 25(1):108-12. PubMed ID: 4435009
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats.
    Olson L; Seiger A; Fuxe K
    Brain Res; 1972 Sep; 44(1):283-8. PubMed ID: 4403485
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML; Lotti VJ; Clark CM; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract]   [Full Text] [Related]  

  • 6. Does dopamine play a role in schizophrenia?
    Carlsson A
    Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Mar; 22(3):241-3. PubMed ID: 4399501
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosine hydroxylase and dopamine-beta-hydroxylase: distribution in discrete areas of the rat limbic system.
    Saavedra JM; Zivin J
    Brain Res; 1976 Apr; 105(3):517-24. PubMed ID: 4197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of dopamine- -hydroxylase in the peripheral and central nervous system.
    Fuxe K; Goldstein M; Hökfelt T; Joh TH
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):627-36. PubMed ID: 4944550
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of desipramine on rat cortex slices incubated with 3H-dopamine.
    Gerlach J; Nielsen M; Randrup A
    Psychopharmacologia; 1974; 37(4):341-9. PubMed ID: 4851622
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC; Giardina WJ; Myles SB; Vazquez AJ
    Arzneimittelforschung; 1974 Mar; 24(3):333-7. PubMed ID: 4407412
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality].
    Toru M; Watanabe S; Kaneno S
    Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.
    Svensson TH
    J Pharm Pharmacol; 1973 Jan; 25(1):73-5. PubMed ID: 4146204
    [No Abstract]   [Full Text] [Related]  

  • 14. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY; Stahl SM
    Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 17. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
    Booth RG; Baldessarini RJ; Marsh E; Owens CE
    Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the anticonvulsant activity of L-dopa by FLA-63, a dopamine- -hydroxylase inhibitor.
    McKenzie GM; Soroko FE
    J Pharm Pharmacol; 1973 Jan; 25(1):76-7. PubMed ID: 4146205
    [No Abstract]   [Full Text] [Related]  

  • 19. Further confirmation of heterogeneity of the rat striatum: different mosaic patterns of dopamine fibers after administration of methamphetamine or reserpine.
    Fukui K; Kariyama H; Kashiba A; Kato N; Kimura H
    Brain Res; 1986 Sep; 382(1):81-6. PubMed ID: 3768683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesolimbic alpha-, but not beta-adrenoceptors control the accumbal release of dopamine that is derived from reserpine-sensitive storage vesicles.
    Verheij MM; Cools AR
    Neuroscience; 2009 Sep; 162(4):1163-73. PubMed ID: 19464350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.